Public Citizen Hopes Democratic House Will Probe FDA DSUVIA Approval

A leading public health advocate official is hopeful the incoming Democratic-led House will investigate FDA’s controversial approval of the sufentanil drug DSUVIA. Sidney Wolfe, founder and senior advisor of Public Citizen’s Health Research Group, told Inside Health Policy he hopes Democrats, with more than a one-vote majority, will move to hold a hearing on the drug’s approval. He said there has been a lack of constructive oversight of FDA under the GOP-controlled House. FDA on Nov. 2 -- despite opposition...